[1]. Balaji M., Chhabda P.J., Srinivasarao V., Appa Rao K.M., Ramakrishna K., Development and validation of a new and stability indicating lc method for analysis of pinaverium bromide in bulk drug and pharmaceutical dosage form. Pharma Science Monitor, 2014, 5 [Google Scholar] [2]. Swetha P., Ravindra K.Y., Ravichander M., LC–MS/MS characterization of forced degradation products of tetrabenazine. Journal of Chemical Sciences, 2016, 7:116 [Google Scholar] [3].  Derangula V.R., Pilli N.R., Nadavala S.K., Adireddy V., Inamadugu J.K., Ponneri V. Biomed Chromatogr., 2013, 27:792 [Crossref], [Google Scholar], [Publisher] [4].  Kaur N., Kumar P., Jamwal S., Deshmukh R., Gauttam V. Tetrabenazine: spotlight on drug review. Annals of neurosciences, 2016, 23:176 [Crossref], [Google Scholar], [Publisher] [5]. Wang H., Chen X., Li Y., Tang T.S., Bezprozvanny I., Tetrabenazine is neuroprotective in Huntington's disease mice. Molecular neurodegeneration, 2010, 5:18 [Google Scholar] [6]. Osório A.C., da Cunha A.L., Khan S., Ponciano C.R., Aucélio R.Q., Spectrofluorimetric determination of tetrabenazine after photochemical derivatization in basic medium. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2013, 100:166 [Crossref], [Google Scholar], [Publisher] [7]. Mehvar R., Jamali F., Watson M.W., Skelton D., Direct injection high-performance liquid chromatography of tetrabenazine and its metabolite in plasma of humans and rats. Journal of pharmaceutical sciences, 1986, 75:1006 [Crossref], [Google Scholar], [Publisher]